2020
DOI: 10.1101/2020.02.11.943845
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

ADAR1 can drive Multiple Myeloma progression by acting both as an RNA editor of specific transcripts and as a DNA mutator of their cognate genes

Abstract: RNA editing is an epitranscriptomic modification of emerging relevance to disease development and manifestations. ADAR1, which resides on human chromosome 1q21, is an RNA editor whose over-expression, either by interferon (IFN) induction or through gene amplification, is associated with increased editing and poor outcomes in Multiple Myeloma (MM). Here we explored the role of ADAR1 in the context of MM progression, by focusing on a group of 23 patients in the MMRF CoMMpass Study for which RNAseq and WES datase… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 61 publications
(35 reference statements)
0
1
0
Order By: Relevance
“…1 Indications exist that the DNA mutation rate due to RNA editing enzymes, though lower than the RNA editing rate, is still much higher than the human genome-wide average mutation rate (Saraconi et al, 2014;Tasakis et al, 2020).…”
Section: Mutational Replacement Of Rna Editingmentioning
confidence: 99%
“…1 Indications exist that the DNA mutation rate due to RNA editing enzymes, though lower than the RNA editing rate, is still much higher than the human genome-wide average mutation rate (Saraconi et al, 2014;Tasakis et al, 2020).…”
Section: Mutational Replacement Of Rna Editingmentioning
confidence: 99%